Clinical trial

A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times…

NCT00330798 · Alcon Research, Industry · Completed

Key facts

NCT number NCT00330798
Title A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
Official title A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study
Lead sponsor Alcon Research, Industry
Collaborators Matthew Caldwell
Status Completed
Phase Phase 4
Study type Interventional
Conditions Photorefractive Keratectomy
Intervention type Drug, Other
Interventions nepafenac 0.1%, ketorolac 0.4%
Enrollment 40
Start date Feb 1, 2006
Primary completion Jun 1, 2006
Completion Jun 1, 2006
First posted May 29, 2006
Last update posted Nov 18, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies